These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
3. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Seed CR; Kiely P; Keller AJ Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258 [TBL] [Abstract][Full Text] [Related]
4. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts. Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028 [TBL] [Abstract][Full Text] [Related]
5. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection. Cheruvu S; Marks K; Talal AH Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235 [TBL] [Abstract][Full Text] [Related]
6. Preventing the transmission of bloodborne pathogens in health care and public service settings. Can Commun Dis Rep; 1997 May; 23 Suppl 3():i-vii, 1-43, i-vii, 1-52. PubMed ID: 11195251 [No Abstract] [Full Text] [Related]
7. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults. Bailey CL; Smith V; Sands M Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596 [TBL] [Abstract][Full Text] [Related]
9. [Amniocentesis and viral risk (hepatitis B, C virus and HIV)]. Ducarme G; Ceccaldi PF; Bernuau J; Luton D J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):469-73. PubMed ID: 19679409 [TBL] [Abstract][Full Text] [Related]
10. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca]. Boutayeb H; Aamoum A; Benchemsi N East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791 [TBL] [Abstract][Full Text] [Related]
11. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology. Delwart E; Kuhns MC; Busch MP J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875 [TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B and C virological tests: interpretation and practical results in women]. Bernard PH Gynecol Obstet Fertil; 2005 Jun; 33(6):423-8. PubMed ID: 15927514 [TBL] [Abstract][Full Text] [Related]
13. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users. Kretzschmar M; Wiessing L AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020 [TBL] [Abstract][Full Text] [Related]
15. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069 [TBL] [Abstract][Full Text] [Related]
16. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
17. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123 [TBL] [Abstract][Full Text] [Related]
18. Bloodborne viruses and occupational exposure in the dental setting. Webber LM SADJ; 2000 Sep; 55(9):494-6. PubMed ID: 12608211 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital. Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414 [TBL] [Abstract][Full Text] [Related]
20. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]